[go: up one dir, main page]

NO20044606L - Polymorfe former av lansoprazol og fremgangsmater for fremstilling derav - Google Patents

Polymorfe former av lansoprazol og fremgangsmater for fremstilling derav

Info

Publication number
NO20044606L
NO20044606L NO20044606A NO20044606A NO20044606L NO 20044606 L NO20044606 L NO 20044606L NO 20044606 A NO20044606 A NO 20044606A NO 20044606 A NO20044606 A NO 20044606A NO 20044606 L NO20044606 L NO 20044606L
Authority
NO
Norway
Prior art keywords
lansoprazole
processes
preparation
polymorphic forms
forms
Prior art date
Application number
NO20044606A
Other languages
English (en)
Inventor
Nina Finkelstein
Shlomit Wizel
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20044606L publication Critical patent/NO20044606L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse gjelder tre krystallinske, faste former av lanzoprazol med formel (I), betegnet form D, E og F. Fremgangsmåter for fremstilling av disse krystallinske, faste formene av lansoprazol beskrives. (I)
NO20044606A 2002-03-27 2004-10-26 Polymorfe former av lansoprazol og fremgangsmater for fremstilling derav NO20044606L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36782002P 2002-03-27 2002-03-27
PCT/US2003/009261 WO2003082857A2 (en) 2002-03-27 2003-03-27 Lansoprazole polymorphs and processes for preparation thereof

Publications (1)

Publication Number Publication Date
NO20044606L true NO20044606L (no) 2004-10-26

Family

ID=28675405

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044606A NO20044606L (no) 2002-03-27 2004-10-26 Polymorfe former av lansoprazol og fremgangsmater for fremstilling derav

Country Status (15)

Country Link
US (1) US20040010151A1 (no)
EP (1) EP1476442A2 (no)
JP (1) JP2005533755A (no)
KR (1) KR20040093187A (no)
CN (1) CN1681802A (no)
AU (1) AU2003224779A1 (no)
CA (1) CA2480352A1 (no)
HR (1) HRP20040979A2 (no)
IL (1) IL164153A0 (no)
IS (1) IS7467A (no)
MX (1) MXPA04009384A (no)
NO (1) NO20044606L (no)
PL (1) PL373539A1 (no)
WO (1) WO2003082857A2 (no)
ZA (1) ZA200407799B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
AU2003273000A1 (en) * 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
KR101376360B1 (ko) 2004-09-13 2014-03-20 다케다 야쿠힌 고교 가부시키가이샤 산화 화합물 제조 방법 및 제조 장치
EP1681056A1 (en) 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Process for preparing lansoprazole
KR100758600B1 (ko) * 2006-01-05 2007-09-13 주식회사 대웅제약 란소프라졸 결정형 ａ의 제조방법
EP2007768A2 (en) * 2006-04-20 2008-12-31 Teva Pharmaceutical Industries Ltd Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
WO2008068767A2 (en) * 2006-12-07 2008-06-12 Hetero Drugs Limited A novel crystalline form of lansoprazole
AU2007341984B2 (en) 2006-12-29 2012-07-05 Il Yang Pharmaceutical Company, Ltd. Solid state forms of racemic ilaprazole
IT1391758B1 (it) * 2008-11-11 2012-01-27 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo amorfo
IT1392813B1 (it) * 2009-02-06 2012-03-23 Dipharma Francis Srl Forme cristalline di dexlansoprazolo
KR20100101405A (ko) * 2009-03-09 2010-09-17 한미홀딩스 주식회사 비결정형의 (+)-란소프라졸 제조방법 및 이에 사용되는 (+)-란소프라졸 알코올레이트
WO2011004387A2 (en) * 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
CN102108076B (zh) * 2009-12-23 2014-07-23 江苏豪森医药集团有限公司 制备无定形右兰索拉唑的方法
US8853411B2 (en) 2010-03-31 2014-10-07 Ranbaxy Laboratories Limited Process for the preparation of dexlansoprazole
EP2663306A4 (en) * 2011-01-12 2014-01-01 Hetero Research Foundation POLYMORPHS OF DEXLANSOPRAZOLE SALTS
AU2014348523B2 (en) 2013-11-15 2019-01-03 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
CN103664889B (zh) * 2013-12-19 2014-11-19 悦康药业集团有限公司 一种兰索拉唑化合物
CN104844576B (zh) * 2015-04-28 2017-03-08 山东罗欣药业集团股份有限公司 一种兰索拉唑或右旋兰索拉唑晶型化合物及其制备方法
CN104829594A (zh) * 2015-05-15 2015-08-12 苗怡文 一种治疗胃溃疡的药物兰索拉唑化合物
CN104958276A (zh) * 2015-07-30 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃溃疡的药物兰索拉唑组合物胶囊
CN104997738A (zh) * 2015-08-10 2015-10-28 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃病的药物兰索拉唑组合物干混悬剂
CN107011328B (zh) * 2017-05-05 2019-10-15 广州大光制药有限公司 一种兰索拉唑化合物的晶型及其结晶制备方法
CN108794450B (zh) * 2018-07-24 2022-08-19 浙江恒康药业股份有限公司 制备无定型右旋兰索拉唑的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives
TWI289557B (en) * 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
PL333847A1 (en) * 1999-06-18 2001-01-02 Inst Farmaceutyczny Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
EP1191025B1 (en) * 1999-06-30 2005-06-22 Takeda Pharmaceutical Company Limited Crystals of lansoprazole
TWI290922B (en) * 2000-12-01 2007-12-11 Takeda Chemical Industries Ltd Production method of crystals
CN100347167C (zh) * 2001-02-02 2007-11-07 特瓦制药工业有限公司 取代的2－(2－吡啶基甲基)亚磺酰基－1h－苯并咪唑化合物的生产方法

Also Published As

Publication number Publication date
WO2003082857A2 (en) 2003-10-09
KR20040093187A (ko) 2004-11-04
PL373539A1 (en) 2005-09-05
AU2003224779A1 (en) 2003-10-13
ZA200407799B (en) 2006-07-26
MXPA04009384A (es) 2005-01-25
EP1476442A2 (en) 2004-11-17
CN1681802A (zh) 2005-10-12
CA2480352A1 (en) 2003-10-09
US20040010151A1 (en) 2004-01-15
HRP20040979A2 (en) 2005-06-30
IS7467A (is) 2004-09-23
IL164153A0 (en) 2005-12-18
WO2003082857A3 (en) 2003-12-18
JP2005533755A (ja) 2005-11-10

Similar Documents

Publication Publication Date Title
NO20044606L (no) Polymorfe former av lansoprazol og fremgangsmater for fremstilling derav
NO20074666L (no) Imidazo(1,2-A)pyridinforbindelser som VEGF-R2-inhibitorer
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
NO20050828L (no) lndol-3-svovelderivater
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
TNSN05194A1 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
NO20066055L (no) Pyridinderivater
WO2006021881A3 (en) Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
NO20054080L (no) Aminoheteroarylforbindelser som roteinkinaseinhibitorer
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
TW200616996A (en) Compounds, compositions and methods
PL374191A1 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
WO2003009855A3 (de) Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen
TW200510407A (en) Novel pyrrolodihydroisoquinolines as PDE 10 inhibitors
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
MY148375A (en) Delta and epsilon crystal forms of imatinib mesylate
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
NO20076681L (no) Ny metode for fremstilling av tiotropiumsalter
IL165558A0 (en) N-benzoylureidocinnamate derivatives method for production and use thereof
NO20040604L (no) Trisykliske imidazolpyridiner
NO20071805L (no) Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere.
TW200612964A (en) Methods for preparing p2x7 inhibitors
NO20064351L (no) Caspaseinhibitorer og anvendelser derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application